Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Chronic Sildenafil for Severe Diaphragmatic Hernia
Chronic Sildenafil for Severe Diaphragmatic Hernia
Status: Enrolling
Updated:  7/16/2012
University of California San Francisco Children's Hospital
mi
from
San Francisco, CA
Chronic Sildenafil for Severe Diaphragmatic Hernia
Chronic Sildenafil for Severe Diaphragmatic Hernia
Status: Enrolling
Updated: 7/16/2012
University of California San Francisco Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Chronic Sildenafil for Severe Diaphragmatic Hernia
Chronic Sildenafil for Severe Diaphragmatic Hernia
Status: Enrolling
Updated:  7/16/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Chronic Sildenafil for Severe Diaphragmatic Hernia
Chronic Sildenafil for Severe Diaphragmatic Hernia
Status: Enrolling
Updated: 7/16/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Vitamin D Treatment in Ulcerative Colitis
Vitamin D Treatment in Ulcerative Colitis
Status: Enrolling
Updated:  7/16/2012
Northshore
mi
from
Evanston, IL
Vitamin D Treatment in Ulcerative Colitis
Vitamin D Treatment in Ulcerative Colitis
Status: Enrolling
Updated: 7/16/2012
Northshore
mi
from
Evanston, IL
Click here to add this to my saved trials
Acupuncture Treatment for Gastroparesis: a Pilot Study
Acupuncture Treatment for Gastroparesis: a Pilot Study
Status: Enrolling
Updated:  7/16/2012
Johns Hopkins Integrative Medicine & Digestive Center
mi
from
Lutherville, MD
Acupuncture Treatment for Gastroparesis: a Pilot Study
Acupuncture Treatment for Gastroparesis: a Pilot Study
Status: Enrolling
Updated: 7/16/2012
Johns Hopkins Integrative Medicine & Digestive Center
mi
from
Lutherville, MD
Click here to add this to my saved trials
Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members
Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members
Status: Enrolling
Updated:  7/17/2012
University of California, San Diego
mi
from
San Diego, CA
Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members
Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members
Status: Enrolling
Updated: 7/17/2012
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Status: Enrolling
Updated:  7/18/2012
Hartford Dispensary
mi
from
Hartford, CT
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Status: Enrolling
Updated: 7/18/2012
Hartford Dispensary
mi
from
Hartford, CT
Click here to add this to my saved trials
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Status: Enrolling
Updated:  7/24/2012
University of California, Davis Medical Center
mi
from
Sacramento, CA
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Status: Enrolling
Updated: 7/24/2012
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
The Effect of Food Taste, Temperature, and Viscosity on Swallowing Efficiency
The Effect of Food Taste, Temperature, and Viscosity on Swallowing Efficiency
Status: Enrolling
Updated:  7/24/2012
UC Davis Department of Otolaryngology
mi
from
Sacramento, CA
The Effect of Food Taste, Temperature, and Viscosity on Swallowing Efficiency
The Effect of Food Taste, Temperature, and Viscosity on Swallowing Efficiency
Status: Enrolling
Updated: 7/24/2012
UC Davis Department of Otolaryngology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults
A Single Center, Randomized, Single-blind Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Split-Dose Regimen of Crystalline Lactulose for Cleansing of the Colon as a Preparation for Colonoscopy in Adults
Status: Enrolling
Updated:  7/24/2012
Virginia Mason Medical Center
mi
from
Seattle, WA
Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults
A Single Center, Randomized, Single-blind Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Split-Dose Regimen of Crystalline Lactulose for Cleansing of the Colon as a Preparation for Colonoscopy in Adults
Status: Enrolling
Updated: 7/24/2012
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose, 2-Period Crossover Study to Evaluate the Pharmacodynamics of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated:  7/26/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose, 2-Period Crossover Study to Evaluate the Pharmacodynamics of RM-131 Administered to Patients With Diabetic Gastroparesis
Status: Enrolling
Updated: 7/26/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease
Association of Serum Infliximab and Antibodies Toward Infliximab (ATI) to Clinical Outcomes in Crohn's Disease
Status: Enrolling
Updated:  7/26/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease
Association of Serum Infliximab and Antibodies Toward Infliximab (ATI) to Clinical Outcomes in Crohn's Disease
Status: Enrolling
Updated: 7/26/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
The University of California, San Diego
mi
from
La Jolla, CA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Santa Monica Research Institute
mi
from
Santa Monica, CA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Santa Monica Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Western States Clinical Research Inc.
mi
from
Wheatridge, CO
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Western States Clinical Research Inc.
mi
from
Wheatridge, CO
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
University of Florida
mi
from
Gainesville, FL
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Shafran Gasteroenterology Center
mi
from
Winter Park, FL
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Shafran Gasteroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Health Science Research Center
mi
from
Pratt, KA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Health Science Research Center
mi
from
Pratt, KA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
University of Kentucky
mi
from
Lexington, KY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Medical Dental Complex
mi
from
Louisville, KY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Medical Dental Complex
mi
from
Louisville, KY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
mi
from
Chevy Chase, MD
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Midwest Center For Clinical Research
mi
from
Lee'S Summit, MO
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Midwest Center For Clinical Research
mi
from
Lee'S Summit, MO
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Long Island Clinical Research Assoc., Llp
mi
from
Great Neck, NY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Long Island Clinical Research Assoc., Llp
mi
from
Great Neck, NY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Gastroenterology Research Of Lima
mi
from
Lima, OH
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Gastroenterology Research Of Lima
mi
from
Lima, OH
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Pharma Resource
mi
from
East Providence, RI
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Pharma Resource
mi
from
East Providence, RI
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Nashville Medical Research Institute
mi
from
Nashville, TN
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Nashville Medical Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated:  8/1/2012
Gastroenterology Research Of San Antonio
mi
from
San Antonio, TX
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
A Phase IIb Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Ulcerative Colitis (UC)
Status: Enrolling
Updated: 8/1/2012
Gastroenterology Research Of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids
Prospective Single Blinded Randomized Controlled Trial Comparing The Covidien EEA™ Hemorrhoid and Prolapse Stapling Set With DST Series™ Technology Vs. Ethicon PPH03 In A Hemorrhoidopexy Procedure (HEMOSTASIS)
Status: Enrolling
Updated:  8/8/2012
USF Tampa General Hospital Dept of Surgery
mi
from
Tampa, FL
Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids
Prospective Single Blinded Randomized Controlled Trial Comparing The Covidien EEA™ Hemorrhoid and Prolapse Stapling Set With DST Series™ Technology Vs. Ethicon PPH03 In A Hemorrhoidopexy Procedure (HEMOSTASIS)
Status: Enrolling
Updated: 8/8/2012
USF Tampa General Hospital Dept of Surgery
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Fayetteville, AK
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Fayetteville, AK
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Aurora, CO
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Washington,
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Miami, FL
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Athens, GA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Athens, GA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Iowa City, IA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Topeka, KA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Alexandria, LA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Scarborough, ME
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Bethesda, MD
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Boston, MA
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Lansing, MI
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated:  8/10/2012
Clinical Research Facility
mi
from
Minneapolis, MN
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach
Status: Enrolling
Updated: 8/10/2012
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials